Autres langues OssDsign AB

Actions

OSSD

SE0012570448

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:21:23 03/05/2024			Varia. 5j.	Varia. 1 janv.
10,28 ^SEK	+5,76 %		+11,26 %	+28,50 %

29/04	OssDsign AB (publ.) élargit son accès aux militaires grâce à un nouveau contrat couvrant 100 hôpitaux orthopédiques VA supplémentaires	CI
02/04	OssDsign signe un contrat d'approvisionnement de trois ans avec Premier pour des produits osseux et de substitution osseuse	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals	29/04
OssDsign AB Expands Military Access with New Contract Covering 100 Additional VA Orthopedic Hospitals	29/04
Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.	15/04
OssDsign: Another quarter of triple-digit Catalyst growth expected	11/04
OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products	02/04
OssDsign awarded long-term agreement with Premier, Inc.	02/04
OssDsign AB Wins Long-Term Agreement with Premier, Inc	02/04
OssDsign: Update after HC seminar and news in the spinal fusion market	07/03
Sweden's OssDsign Names Chief Technical Officer	29/02
OssDsign appoints Tom Buckland as Chief Technical Officer	29/02
OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer	29/02
OssDsign: Restructuring completed, focus on 2024	07/02
OssDsign AB (publ) publishes year-end report 2023	06/02
OssDsign AB Reports Earnings Results for the Full Year Ended December 31, 2023	06/02
OssDsign AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/02
OssDsign: Right time to fuse the spine	29/01
12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research	24/01
OssDsign AB (publ.) Announces 12-Month Data from the Clinical Study Top Fusion	24/01
OssDsign reports exceptional data from the clinical study TOP FUSION	09/01
OssDsign AB Reports Exceptional Data from the Clinical Study TOP FUSION	09/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues OssDsign AB

Actions

OSSD

SE0012570448

Autres langues

Filtres